News
News
Academy
Multimedia
Editorial Podcasts
Editorial Videos
Peer Exchange
Profiles in Medicine
Shorts
Conferences
Conference Coverage
Conference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement Hubs
E-Books
Events
Sponsored Podcasts
Sponsored Videos
Webcasts
Whitepapers
Event Calendar
Subscribe
My Account
News
Academy
Multimedia
Conferences
Publications
Partner Perspectives
Resources
Event Calendar
Subscribe
Corporate Communications
Press Releases
Executive Roundtable
Executive Profiles
Leadership
Direct-to-Consumer
Patient Education
Healthcare Access
Telehealth
Emerging Biopharma
Partnerships
Funding
IR Licensing and Partnerships
Finance
Industry Trends
Market Access
Patient Access
Pricing
Strategy
Medical Affairs
Patient Advocacy
Clinical Data
Pharmacovigilance
Operations
Sustainability
Technology
R&D/Clinical Trials
Supply Chain
Patient Engagement
DE&I
Regulatory
FDA
Legal
Global
Sales & Marketing
Sales Effectiveness
Campaigns
DTC Marketing
Medical Education
Choose Topic
Spotlight -
Emerging Pharma Leaders Awards
|
Latest Executive Roundtables
|
Asembia 2026
|
Sales Effectiveness
Advertisement
Frank Saia
Advertisement
Articles by Frank Saia
AI and Social Listening: Myths vs. Facts
By
Frank Saia
August 11th 2020
What’s all the mystery about?
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
Study Shows Link Between Zepbound and Lower Healthcare Costs in Adults Aged 55 and Up with Obesity: Report
3
Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals
4
M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to Acquire Igalmi from BioXcel
5
The Full Path of Drug Development, and Why So Few Drugs Make It: Q&A with Dr. Ying Huang